For the quarter ending 2025-11-30, MDNC had $608,831 increase in cash & cash equivalents over the period.
| Cash Flow | 2025-11-30 | 2025-08-31 | 2025-05-31 |
|---|---|---|---|
| Net cashflow from/(used in) operations | 1,786,677 | - | -759,238 |
| Payments to acquire property, plant, and equipment | - | 0 | 0 |
| Accrued interest | - | - | 0 |
| Total cash flows used in investing activities | - | 0 | 0 |
| Tax paid | - | - | 0 |
| Net Cash Provided By Used In Operating Activities | - | 1,223,538 | - |
| Total cash flows from/(used in) operating activities | 563,139 | 1,223,538 | -759,238 |
| Proceeds from issuance of long-term debt | - | 0 | 0 |
| Repayment of debt | 2,531 | 1,018,367 | -37,900 |
| Total cash flows from/(used by) financing activities | -2,531 | -942,567 | -37,900 |
| Effect of exchange rate on cash and cash equivalents | 48,223 | 16,248 | -21,672 |
| Net increase / (decrease) in cash and cash equivalents | 608,831 | 297,218 | -818,809 |
| Cash and cash equivalents at beginning of period | 2,248,095 | 2,769,686 | - |
| Cash and cash equivalents at end of period | 2,856,926 | 2,248,095 | - |
Medinotec Inc. (MDNC)
Medinotec Inc. (MDNC)